|
1
|
Lepage C, Hamza S and Faivre J:
Epidemiology and screening of colon cancer. Rev Prat. 60:1062–1067.
2010.(In French).
|
|
2
|
Johnson JJ and Mukhtar H: Curcumin for
chemoprevention of colon cancer. Cancer Lett. 255:170–181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bazuro GE, Torino F, Gasparini G and
Capurso L: Chemo-prevention in gastrointestinal adenocarcinoma: For
few but not for all? Minerva Gastroenterol Dietol. 54:429–444.
2008.PubMed/NCBI
|
|
4
|
Linsalata M and Russo F: Nutritional
factors and polyamine metabolism in colorectal cancer. Nutrition.
24:382–389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shearer MJ and Newman P: Metabolism and
cell biology of vitamin K. Thromb Haemost. 100:530–547.
2008.PubMed/NCBI
|
|
6
|
Lamson DW and Plaza SM: The anticancer
effects of vitamin K. Altern Med Rev. 8:303–318. 2003.PubMed/NCBI
|
|
7
|
Mizuta T and Ozaki I: Hepatocellular
carcinoma and vitamin K. Vitam Horm. 78:435–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi
Y, Yasutake T, Sakamaki T, Pestell RG and Yamamoto K:
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular
carcinoma cell growth by suppressing cyclin D1 expression through
inhibition of nuclear factor kappaB activation. Clin Cancer Res.
13:2236–2245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du W, Zhou JR, Wang DL, Gong K and Zhang
QJ: Vitamin K1 enhances sorafenib-induced growth inhibition and
apoptosis of human malignant glioma cells by blocking the
Raf/MEK/ERK pathway. World J Surg Oncol. 10:602012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Orlando A, Linsalata M, Tutino V, D'Attoma
B, Notarnicola M and Russo F: Vitamin K1 exerts antiproliferative
effects and induces apoptosis in three differently graded human
colon cancer cell lines. BioMed Res Int. 2015:2967212015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linsalata M, Orlando A, Tutino V,
Notarnicola M, D'Attoma B and Russo F: Inhibitory effect of vitamin
K1 on growth and polyamine biosynthesis of human gastric and colon
carcinoma cell lines. Int J Oncol. 47:773–781. 2015.PubMed/NCBI
|
|
12
|
Thomas T and Thomas TJ: Polyamine
metabolism and cancer. J Cell Mol Med. 7:113–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aureli P, Capurso L, Castellazzi AM,
Clerici M, Giovannini M, Morelli L, Poli A, Pregliasco F, Salvini F
and Zuccotti GV: Probiotics and health: an evidence-based review.
Pharmacol Res. 63:366–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumar M, Kumar A, Nagpal R, Mohania D,
Behare P, Verma V, Kumar P, Poddar D, Aggarwal PK, Henry CJ, et al:
Cancer-preventing attributes of probiotics: An update. Int J Food
Sci Nutr. 61:473–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Linsalata M, Russo F, Berloco P, Valentini
AM, Caruso ML, De Simone C, Barone M, Polimeno L and Di Leo A:
Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis
and cell proliferation of normal colonic mucosa of rats. In Vivo.
19:989–995. 2005.PubMed/NCBI
|
|
16
|
Uccello M, Malaguarnera G, Basile F,
D'agata V, Malaguarnera M, Bertino G, Vacante M, Drago F and Biondi
A: Potential role of probiotics on colorectal cancer prevention.
BMC Surg. 12(Suppl 1): S352012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You HJ, Oh DK and Ji GE: Anticancerogenic
effect of a novel chiroinositol-containing polysaccharide from
Bifidobacterium bifidum BGN4. FEMS Microbiol Lett. 240:131–136.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Orlando A, Messa C, Linsalata M, Cavallini
A and Russo F: Effects of Lactobacillus rhamnosus GG on
proliferation and polyamine metabolism in HGC-27 human gastric and
DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol.
31:108–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Orlando A, Refolo MG, Messa C, Amati L,
Lavermicocca P, Guerra V and Russo F: Antiproliferative and
proapoptotic effects of viable or heat-killed Lactobacillus
paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric
and DLD-1 colon cell lines. Nutr Cancer. 64:1103–1111. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roberfroid M: Prebiotics: The concept
revisited. J Nutr. 137(Suppl 2): 830S–837S. 2007.PubMed/NCBI
|
|
21
|
Gibson GR and Roberfroid MB: Dietary
modulation of the human colonic microbiota: Introducing the concept
of prebiotics. J Nutr. 125:1401–1412. 1995.PubMed/NCBI
|
|
22
|
Bomba A, Nemcová R, Gancarcíková S, Herich
R, Guba P and Mudronová D: Improvement of the probiotic effect of
micro-organisms by their combination with maltodextrins,
fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr.
88(Suppl 1): S95–S99. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wyss C: Growth of Porphyromonas
gingivalis, Treponema denticola, T. pectinovorum, T. socranskii,
and T. vincentii in a chemically defined medium. J Clin Microbiol.
30:2225–2229. 1992.PubMed/NCBI
|
|
24
|
Bowler PG, Duerden BI and Armstrong DG:
Wound microbiology and associated approaches to wound management.
Clin Microbiol Rev. 14:244–269. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hojo K, Nagaoka S, Murata S, Taketomo N,
Ohshima T and Maeda N: Reduction of vitamin K concentration by
salivary Bifidobacterium strains and their possible nutritional
competition with Porphyromonas gingivalis. J Appl Microbiol.
103:1969–1974. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brunner H, Hausmann F, Krieg RC, Endlicher
E, Schölmerich J, Knuechel R and Messmann H: The effects of
5-aminolevulinic acid esters on protoporphyrin IX production in
human adenocarcinoma cell lines. Photochem Photobiol. 74:721–725.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Linsalata M, Notarnicola M, Tutino V,
Bifulco M, Santoro A, Laezza C, Messa C, Orlando A and Caruso MG:
Effects of anandamide on polyamine levels and cell growth in human
colon cancer cells. Anticancer Res. 30:2583–2589. 2010.PubMed/NCBI
|
|
28
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chan AT and Giovannucci EL: Primary
prevention of colorectal cancer. Gastroenterology.
138:2029–2043.e2010. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ligibel J: Lifestyle factors in cancer
survivorship. J Clin Oncol. 30:3697–3704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reid G, Jass J, Sebulsky MT and McCormick
JK: Potential uses of probiotics in clinical practice. Clin
Microbiol Rev. 16:658–672. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liong MT: Roles of probiotics and
prebiotics in colon cancer prevention: Postulated mechanisms and
in-vivo evidence. Int J Mol Sci. 9:854–863. 2008. View Article : Google Scholar
|
|
33
|
Lam EK, Tai EK, Koo MW, Wong HP, Wu WK, Yu
L, So WH, Woo PC and Cho CH: Enhancement of gastric mucosal
integrity by Lactobacillus rhamnosus GG. Life Sci. 80:2128–2136.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Drisko JA, Giles CK and Bischoff BJ:
Probiotics in health maintenance and disease prevention. Altern Med
Rev. 8:143–155. 2003.PubMed/NCBI
|
|
35
|
Yan F and Polk DB: Probiotic bacterium
prevents cytokine-induced apoptosis in intestinal epithelial cells.
J Biol Chem. 277:50959–50965. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Linsalata M, Cavallini A, Messa C, Orlando
A, Refolo MG and Russo F: Lactobacillus rhamnosus GG influences
polyamine metabolism in HGC-27 gastric cancer cell line: A strategy
toward nutritional approach to chemoprevention of gastric cance.
Curr Pharm Des. 16:847–853. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Showalter SL, Wang Z, Costantino CL,
Witkiewicz AK, Yeo CJ, Brody JR and Carr BI: Naturally occurring K
vitamins inhibit pancreatic cancer cell survival through a
caspase-dependent pathway. J Gastroenterol Hepatol. 25:738–744.
2010. View Article : Google Scholar
|
|
38
|
Moreno-Vilet L, Garcia-Hernandez MH,
Delgado-Portales RE, Corral-Fernandez NE, Cortez-Espinosa N,
Ruiz-Cabrera MA and Portales-Perez DP: In vitro assessment of agave
fructans (Agave salmiana) as prebiotics and immune system
activators. Int J Biol Macromol. 63:181–187. 2014. View Article : Google Scholar
|
|
39
|
Tokita H, Tsuchida A, Miyazawa K,
Ohyashiki K, Katayanagi S, Sudo H, Enomoto M, Takagi Y and Aoki T:
Vitamin K2-induced antitumor effects via cell-cycle arrest and
apoptosis in gastric cancer cell lines. Int J Mol Med. 17:235–243.
2006.PubMed/NCBI
|
|
40
|
Mouradov D, Sloggett C, Jorissen RN, Love
CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald
S, et al: Colorectal cancer cell lines are representative models of
the main molecular subtypes of primary cancer. Cancer Res.
74:3238–3247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Flatmark K, Maelandsmo GM, Martinsen M,
Rasmussen H and Fodstad Ø: Twelve colorectal cancer cell lines
exhibit highly variable growth and metastatic capacities in an
orthotopic model in nude mice. Eur J Cancer. 40:1593–1598. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Glick MC, Zilliken F and Gyorgy P:
Supplementary growth promoting effect of 2-methyl-1,4
-naphthoquinone of Lactobacillus bifidus var. pennsylvanicus. J
Bacteriol. 77:230–236. 1959.PubMed/NCBI
|
|
43
|
Alander M, Satokari R, Korpela R, Saxelin
M, Vilpponen-Salmela T, Mattila-Sandholm T and von Wright A:
Persistence of colonization of human colonic mucosa by a probiotic
strain, Lactobacillus rhamnosus GG, after oral consumption. Appl
Environ Microbiol. 65:351–354. 1999.PubMed/NCBI
|
|
44
|
Wei G, Wang M, Hyslop T, Wang Z and Carr
BI: Vitamin K enhancement of sorafenib-mediated HCC cell growth
inhibition in vitro and in vivo. Int J Cancer. 127:2949–2958. 2010.
View Article : Google Scholar :
|
